Elizabeth S. McDonald, MD
Radiology

Elizabeth S. McDonald, MD

Radiology
Accepting new patients
Sees patients age 18 and up
Penn Medicine Provider

About me

  • Director, Breast MRI
  • Co-Director, Breast Cancer Translational Research Group
  • Program Director, Breast/Women's Imaging Fellowship
  • Professor of Radiology at the Hospital of the University of Pennsylvania

My education and training

  • Mayo Graduate School of MedicineMedical School
  • Mayo ClinicResidency
  • Mayo ClinicFellowship
  • University of Washington HospitalsFellowship

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Penn Medicine hospital privileges

  • Chester County Hospital: Has privileges to treat patients in the hospital.
  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
Dr. McDonald is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

McDonald, ES, Scheel, JR, Lewin, AA, Weinstein, SP, Dodelzon, K, Dogan, BE, Fitzpatrick, A, Kuzmiak, CM, Newell, MS, Paulis, LV, Pilewskie, M, Salkowski, LR, Sanford, MF, Silva, C, Sharpe, RE, Specht, J, Ulaner, GA, Slanetz, PJ. ACR Appropriateness Criteria Imaging of Invasive Breast Cancer. , Journal of the American College of Radiology: 2024,S168-S202


Young, AJ, Pantel, AR, Kiani, M, Doot, RK, Bagheri, S, Pryma, DA, Farwell, MD, Li, S, Lee, H, Schubert, E, Secreto, A, Zuckerman, S, Nayak, A, Choi, H, Carlin, S, DeMichele, A, Mankoff, DA, Zhou, R, Mach, RH, McDonald, ES. "Kinetic Analysis and Metabolism of Poly-(Adenosine Diphosphate- Ribose) Polymerase-1–Targeted 18F-Fluorthanatrace PET in Breast Cancer" , Journal of Nuclear Medicine: 2024


McDonald, ES, Pan, T, Pant, DK, Troester, MA, Kossenkov, AV, Mankoff, DA, Mach, RH, Chodosh, L. Ternary Complex Components Responsible for Rapid LDL Internalization as Biomarkers for Breast Cancer Associated with Proliferation and Early Recurrence , Cancer Research Communications, 5: 2025,226-239


McDonald, ES, Doot, RK, Pantel, AR, Farwell, MD, Mach, RH, Maxwell, KN, Mankoff, DA Positron Emission Tomography Imaging of Poly-(Adenosine Diphosphate-Ribose) Polymerase 1 Expression in Breast Cancer: A Nonrandomized Clinical Trial , JAMA Oncology, 6(6): 2020,921-923


Zuckerman S and McDonald ES Mammography Quality Standards Act (MQSA) and ACR Accreditation Programs , CORE Requisites series in breast imaging: 2022


McDonald ES, Pantel AR, Shah PD, Farwell MD, Clark AS, Doot RK, Pryma DA, Carlin SD. In vivo visualization of PARP inhibitor pharmacodynamics , JCI Insight, 6(8): 2022,e146592.


McDonald ES, Romanoff J, Rahbar H, Kitsch AE, Harvey SM, Whisenant JG, Yankeelov TE, Moy L, DeMartini WB, Dogan BE, Yang WT, Wang LC, Joe BN, Wilmes LJ, Hylton NM, Oh KY, Tudorica LA, Neal CH, Malyarenko DI, Comstock CE, Schnall MD, Chenevert TL, Partridge SC. Mean Apparent Diffusion Coefficient Is a Sufficient Conventional Diffusion-weighted MRI Metric to Improve Breast MRI Diagnostic Performance: Results from the ECOG-ACRIN Cancer Research Group A6702 Diffusion Imaging Trial , Radiology, 298(1): 2021,60-70


Chitalia, R., Pati, S., Bhalerao, M., Thakur, S., Jahani, N., Belenky, J. V., McDonald, E., Gibbs, J., Newitt, D., Hylton, N., Kontos, D., & Bakas, S. Expert tumor annotations and radiomic features for the ISPY1/ACRIN 6657 trial data collection [Data set]. , The Cancer Imaging Archive. (NCI): 2022


Lee, HS, Schwarz, SW, Schubert, EK, Chen, DL, Doot, RK, Makvandi, M, Lin, LL, McDonald, ES, Mankoff, DA, Mach, RH. The Development of 18F Fluorthanatrace: A PET Radiotracer for Imaging Poly (ADP-Ribose) Polymerase-1 , Radiol Imaging Cancer, 4(1): 2022,e210070.


O'Brien SR, Ward R, Wu GG, Bagheri S, Kiani M, Challa A, Ulaner GA, Pantel AR, McDonald ES. Other Novel PET Radiotracers for Breast Cancer , PET Clin, 18(4): 2023,557-566